Luc E. Coffeng

ORCID: 0000-0002-4425-2264
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Parasites and Host Interactions
  • Parasitic Diseases Research and Treatment
  • Parasite Biology and Host Interactions
  • Helminth infection and control
  • Global Maternal and Child Health
  • Insects and Parasite Interactions
  • Research on Leishmaniasis Studies
  • Child Nutrition and Water Access
  • Mosquito-borne diseases and control
  • COVID-19 epidemiological studies
  • Malaria Research and Control
  • Trypanosoma species research and implications
  • Insect symbiosis and bacterial influences
  • Health disparities and outcomes
  • Zoonotic diseases and public health
  • Dermatological diseases and infestations
  • Global Health Care Issues
  • Data-Driven Disease Surveillance
  • Viral Infections and Vectors
  • Mental Health Research Topics
  • COVID-19 Digital Contact Tracing
  • Parasitic Infections and Diagnostics
  • Vaccine Coverage and Hesitancy
  • Infant Nutrition and Health
  • Leprosy Research and Treatment

Erasmus University Rotterdam
2012-2024

Erasmus MC
2015-2024

University of Oxford
2022

Swiss Tropical and Public Health Institute
2022

University of Basel
2022

Imperial College London
2022

Radboud University Nijmegen
2022

Radboud University Medical Center
2022

University of Warwick
2022

ORCID
2020-2021

Rafael Lozano Mohsen Naghavi Kyle J Foreman Stephen S Lim Kenji Shibuya and 95 more Victor Aboyans Jerry Abraham Tim Adair Rakesh Aggarwal Stephanie Y Ahn Mohammad A. AlMazroa Miriam Alvarado H Ross Anderson Laurie Anderson Kathryn Andrews Charles Atkinson Larry M. Baddour Suzanne Barker‐Collo David Bartels Michelle L. Bell Emelia J. Benjamin Derrick Bennett Kavi Bhalla Boris Bikbov Aref Bin Abdulhak Gretchen L. Birbeck Fiona Blyth Ian Bolliger Soufiane Boufous Chiara Bucello Michael Burch Peter Burney Jonathan R. Carapetis Honglei Chen David Chou Sumeet S Chugh Luc E. Coffeng Steven D Colan Samantha Colquhoun K. Ellicott Colson John R. Condon Myles Connor Leslie T. Cooper Matthew Corriere Monica Cortinovis Karen Courville William Couser Benjamin C Cowie Michael H Criqui Marita Cross Kaustubh Dabhadkar Nabila Dahodwala Diego De Leo Louisa Degenhardt Allyne Delossantos Julie O. Denenberg Don C. Des Jarlais Samath D Dharmaratne E. Ray Dorsey Tim Driscoll Herbert C. Duber Beth E. Ebel Patricia J. Erwin Patricia Espindola Majid Ezzati Valery L. Feigin Abraham D Flaxman Mohammad H Forouzanfar F.G.R. Fowkes Richard C. Franklin Marlene Fransen Michael K Freeman Sherine E. Gabriel Emmanuela Gakidou Flavio Gaspari Richard F Gillum Diego González-Medina Yara A. Halasa Diana Haring James Harrison Rasmus Havmoeller Roderick J. Hay Bruno Hoen Peter J. Hotez Damian Hoy Kathryn H. Jacobsen Spencer L James Rashmi Jasrasaria Sudha Jayaraman Nicole E. Johns Ganesan Karthikeyan Nicholas J Kassebaum Andre Keren Jon‐Paul Khoo Lisa M. Knowlton Olive Kobusingye Adofo Koranteng Rita Krishnamurthi Michael S. Lipnick Steven E Lipshultz

10.1016/s0140-6736(12)61728-0 article EN The Lancet 2012-12-01
Christopher J L Murray Theo Vos Rafael Lozano Mohsen Naghavi Abraham D Flaxman and 95 more Catherine Michaud Majid Ezzati Kenji Shibuya Joshua A. Salomon Safa Abdalla Victor Aboyans Jerry Abraham Ilana N. Ackerman Rakesh Aggarwal Stephanie Y Ahn Mohammed K. Ali Mohammad A. AlMazroa Miriam Alvarado H Ross Anderson Laurie Anderson Kathryn Andrews Charles Atkinson Larry M. Baddour Adil N Bahalim Suzanne Barker‐Collo Lope H Barrero David Bartels Marı́a-Gloria Basáñez Amanda Baxter Michelle L. Bell Emelia J. Benjamin Derrick Bennett Eduardo Bernabé Kavi Bhalla Bishal Bhandari Boris Bikbov Aref Bin Abdulhak Gretchen L. Birbeck James A Black Hannah Blencowe Jed D Blore Fiona Blyth Ian Bolliger Audrey Bonaventure Soufiane Boufous Rupert Bourne Michel Boussinesq Tasanee Braithwaite Carol Brayne Lisa Bridgett Simon Brooker Peter Brooks Traolach Brugha Claire Bryan-Hancock Chiara Bucello Rachelle Buchbinder Geoffrey Buckle Christine M. Budke Michael Burch Peter Burney Roy Burstein Bianca Calabria Benjamin Campbell Charles E. Canter Hélène Carabin Jonathan R. Carapetis Loreto Carmona Claudia Cella Fiona J Charlson Honglei Chen Andrew Tai-Ann Cheng David Chou Sumeet S. Chugh Luc E. Coffeng Steven D. Colan Samantha Colquhoun K. Ellicott Colson John R. Condon Myles Connor Leslie T. Cooper Matthew Corriere Monica Cortinovis Karen Courville William Couser Benjamin C Cowie Michael H Criqui Marita Cross Kaustubh Dabhadkar Manu Dahiya Nabila Dahodwala James Damsere-Derry Goodarz Danaei Adrian Davis Diego De Leo Louisa Degenhardt Robert P. Dellavalle Allyne Delossantos Julie O. Denenberg Sarah Derrett Don C. Des Jarlais

10.1016/s0140-6736(12)61689-4 article EN The Lancet 2012-12-01
Theo Vos Abraham D Flaxman Mohsen Naghavi Rafael Lozano Catherine Michaud and 95 more Majid Ezzati Kenji Shibuya Joshua A. Salomon Safa Abdalla Victor Aboyans Jerry Abraham Ilana N. Ackerman Rakesh Aggarwal Stephanie Y Ahn Mohammed K. Ali Mohammad A. AlMazroa Miriam Alvarado H Ross Anderson Laurie Anderson Kathryn Andrews Charles Atkinson Larry M. Baddour Adil N Bahalim Suzanne Barker‐Collo Lope H Barrero David Bartels Marı́a-Gloria Basáñez Amanda Baxter Michelle L. Bell Emelia J. Benjamin Derrick Bennett Eduardo Bernabé Kavi Bhalla Bishal Bhandari Boris Bikbov Aref Bin Abdulhak Gretchen L. Birbeck James A Black Hannah Blencowe Jed D Blore Fiona Blyth Ian Bolliger Audrey Bonaventure Soufiane Boufous Rupert Bourne Michel Boussinesq Tasanee Braithwaite Carol Brayne Lisa Bridgett Simon Brooker Peter Brooks Traolach Brugha Claire Bryan-Hancock Chiara Bucello Rachelle Buchbinder Geoffrey Buckle Christine M. Budke Michael Burch Peter Burney Roy Burstein Bianca Calabria Benjamin Campbell Charles E. Canter Hélène Carabin Jonathan R. Carapetis Loreto Carmona Claudia Cella Fiona J Charlson Honglei Chen Andrew Tai-Ann Cheng David Chou Sumeet S. Chugh Luc E. Coffeng Steven D. Colan Samantha Colquhoun K. Ellicott Colson John R. Condon Myles Connor Leslie T. Cooper Matthew Corriere Monica Cortinovis Karen Courville William Couser Benjamin C Cowie Michael H Criqui Marita Cross Kaustubh Dabhadkar Manu Dahiya Nabila Dahodwala James Damsere-Derry Goodarz Danaei Adrian Davis Diego De Leo Louisa Degenhardt Robert P. Dellavalle Allyne Delossantos Julie O. Denenberg Sarah Derrett Don C. Des Jarlais Samath D Dharmaratne

10.1016/s0140-6736(12)61729-2 article EN The Lancet 2012-12-01

Disability secondary to skin conditions is substantial worldwide. The Global Burden of Disease Study 2013 includes estimates global morbidity and mortality due diseases.To measure the burden diseases worldwide.For nonfatal estimates, data were found by literature search using PubMed Google Scholar in English Spanish for years 1980 through accessing administrative on hospital inpatient outpatient episodes. Data fatal based vital registration verbal autopsy data.Skin disease extracted from...

10.1001/jamadermatol.2016.5538 article EN JAMA Dermatology 2017-03-01
Hmwe Hmwe Kyu Christine Pinho Joseph A. Wagner Jonathan C. Brown Amelia Bertozzi-Villa and 95 more Fiona J Charlson Luc E. Coffeng Lalit Dandona Holly E Erskine Alize J Ferrari Christina Fitzmaurice Thomas Fleming Mohammad H Forouzanfar Nicholas Graetz Caterina Guinovart Juanita A. Haagsma Hideki Higashi Nicholas J Kassebaum Heidi J. Larson Stephen S Lim Ali H. Mokdad Maziar Moradi‐Lakeh Shaun V. Odell Gregory A. Roth Peter Serina Jeffrey D Stanaway Awoke Misganaw Harvey Whiteford Timothy M Wolock Sarah Wulf Hanson Foad Abd-Allah Semaw Ferede Abera Laith J. Abu‐Raddad Fadia AlBuhairan Azmeraw T. Amare Carl Abelardo T. Antonio Al Artaman Suzanne Barker‐Collo Lope H Barrero Corina Benjet Isabela M. Benseñor Zulfiqar A Bhutta Boris Bikbov Alexandra Bražinová Ismael Campos‐Nonato Carlos A Castañeda-Orjuela Ferrán Catalá-López Rajiv Chowdhury Cyrus Cooper John A. Crump Rakhi Dandona Louisa Degenhardt Robert P Dellavalle Samath D Dharmaratne Emerito Jose A Faraon Valery L. Feigin Thomas Fürst Johanna M. Geleijnse Bradford D. Gessner Katherine B. Gibney Atsushi Goto David Gunnell Graeme J. Hankey Roderick J. Hay John Hornberger Hung Chak Ho Guoqing Hu Kathryn H. Jacobsen Sudha Jayaraman Panniyammakal Jeemon Jost B. Jonas André Karch Daniel Kim Sungroul Kim Yoshihiro Kokubo Barthélémy Kuate Defo Burcu Küçük Biçer G Anil Kumar Anders Larsson Janet L Leasher Ricky Leung Yongmei Li Steven E. Lipshultz Alan D López Paulo A. Lotufo Raimundas Lunevičius Ronan A Lyons Marek Majdán Reza Malekzadeh Taufiq Mashal Amanda J. Mason‐Jones Yohannes Adama Melaku Ziad A. Memish Walter Mendoza Ted R. Miller Charles Mock Joseph Murray Sandra Nolte In‐Hwan Oh Bolajoko O. Olusanya

The literature focuses on mortality among children younger than 5 years. Comparable information nonfatal health outcomes these and the fatal burden of diseases injuries older adolescents is scarce.

10.1001/jamapediatrics.2015.4276 article EN JAMA Pediatrics 2016-01-26

The African Programme for Onchocerciasis Control (APOC) was created in 1995 to establish community-directed treatment with ivermectin (CDTi) order control onchocerciasis as a public health problem 20 countries that had 80 % of the global disease burden. When research showed CDTi may ultimately eliminate infection, APOC given 2008 additional objective determine when and where can be safely stopped. We report results epidemiological evaluations undertaken from 2014 assess progress towards...

10.1186/s40249-016-0160-7 article EN cc-by Infectious Diseases of Poverty 2016-06-27

The World Health Organization (WHO) has set ambitious targets for the elimination of onchocerciasis by 2020-2025 through mass ivermectin treatment. Two different mathematical models have assessed feasibility reaching this goal settings and treatment scenarios, namely individual-based microsimulation model ONCHOSIM population-based deterministic EPIONCHO. In study, we harmonize some crucial assumptions compare predictions on common outputs.Using a range initial endemicity levels compared with...

10.1186/s13071-015-1159-9 article EN cc-by Parasites & Vectors 2015-10-21

The new Global Burden of Disease Study 2013 has identified some key trends in the major neglected tropical diseases, many with public health and policy implications.The (GBD) is a landmark initiative that systematically quantifies prevalence, morbidity, mortality for hundreds injuries, risk factors global importance.For diseases (NTDs), GBD 2010 confirmed high disease burden 17 NTDs prioritized by World Health Organization (WHO) as well selected conditions also recognized PLOS Neglected...

10.1371/journal.pntd.0005424 article EN cc-by PLoS neglected tropical diseases 2017-08-03

Background Onchocerciasis causes a considerable disease burden in Africa, mainly through skin and eye disease. Since 1995, the African Programme for Control (APOC) has coordinated annual mass treatment with ivermectin 16 countries. In this study, we estimate health impact of APOC associated costs from program perspective up to 2010 provide expected trends 2015. Methods Findings With data on pre-control prevalence infection population coverage treatment, simulated infection, blindness, visual...

10.1371/journal.pntd.0002032 article EN cc-by PLoS neglected tropical diseases 2013-01-31

Abstract Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that impact of this disruption will vary across diseases. Programs face...

10.1093/cid/ciaa933 article EN cc-by Clinical Infectious Diseases 2020-07-10

Considerable efforts have been made to better understand the effectiveness of large-scale preventive chemotherapy therapy for control morbidity caused by infection with soil-transmitted helminths (STHs): Ascaris lumbricoides, Trichuris trichiura, and 2 hookworm species, Necator americanus Ancylostoma duodenale. Current World Health Organization (WHO) guidelines STH include mass drug administration (MDA) programs based on prevalence measurements, aiming at reducing in pre-school-aged children...

10.1093/cid/ciy002 article EN cc-by Clinical Infectious Diseases 2018-01-26

Abstract Control of soil-transmitted helminths relies heavily on regular large-scale deworming high-risk groups (e.g., children) with benzimidazole derivatives. Although drug resistance has not yet been documented in human helminths, cattle and sheep led to widespread veterinary helminths. Here we predict the population dynamics helminth infections during 20 years preventive chemotherapy, using an individual-based model. With current chemotherapy strategy mainly targeting children schools,...

10.1038/s41467-024-45027-2 article EN cc-by Nature Communications 2024-02-06

Quantitative analysis and mathematical models are useful tools in informing strategies to control or eliminate disease. Currently, there is an urgent need develop these inform policy achieve the 2020 goals for neglected tropical diseases (NTDs). In this paper we give overview of a collection novel model-based analyses which aim address key questions on dynamics transmission nine NTDs: Chagas disease, visceral leishmaniasis, human African trypanosomiasis, leprosy, soil-transmitted helminths,...

10.1186/s13071-015-1235-1 article EN cc-by Parasites & Vectors 2015-12-01

Background The initial endemicity (pre-control prevalence) of onchocerciasis has been shown to be an important determinant the feasibility elimination by mass ivermectin distribution. We present first geostatistical map microfilarial prevalence in former Onchocerciasis Control Programme West Africa (OCP) before commencement antivectorial and antiparasitic interventions. Methods Findings Pre-control data from 737 villages across 11 constituent countries OCP epidemiological database were used...

10.1371/journal.pntd.0004328 article EN cc-by PLoS neglected tropical diseases 2016-01-15

Malaria elimination strategies require a thorough understanding of parasite transmission from human to mosquito. A clinical model induce gametocytes understand their dynamics and evaluate transmission-blocking interventions (TBI) is currently unavailable. Here, we explore the use well-established Controlled Human Infection (CHMI) gametocyte carriage with different antimalarial drug regimens.

10.7554/elife.31549 article EN cc-by eLife 2018-02-27

Scabies is a neglected tropical disease (NTD) that causes significant health burden, particularly in disadvantaged communities and where there overcrowding. There emerging evidence ivermectin-based mass drug administration (MDA) can reduce the prevalence of scabies some settings, but remains limited, are no formal guidelines to inform control efforts. An informal World Health Organization (WHO) consultation was organized find agreement on strategies for global control. The resulted framework...

10.1371/journal.pntd.0009661 article EN public-domain PLoS neglected tropical diseases 2021-09-02

The estimation of parameters and model structure for informing infectious disease response has become a focal point the recent pandemic. However, it also highlighted plethora challenges remaining in fast robust extraction information using data models to help inform policy. In this paper, we identify discuss four broad paradigm relating modelling, namely Uncertainty Quantification framework, estimation, model-based inference prediction, expert judgement. We postulate priorities methodology...

10.1016/j.epidem.2022.100547 article EN cc-by-nc-nd Epidemics 2022-02-10

The African Programme for Onchocerciasis Control (APOC) is currently shifting its focus from morbidity control to elimination of infection. To enhance the likelihood and speed up achievement, programs may consider increase frequency ivermectin mass treatment annual 6-monthly or even higher. In a computer simulation study, we examined potential impact increasing different settings. With ONCHOSIM model, simulated 92,610 scenarios pertaining assumptions about transmission conditions, history...

10.1371/journal.pone.0115886 article EN cc-by PLoS ONE 2014-12-29

Globally, hookworms infect 440 million people in developing countries. Especially children and women of childbearing age are at risk anaemia as a result infection. To control hookworm infection disease (i.e. reduce the prevalence medium heavy to <1 %), World Health Organization has set target provide annual or semi-annual preventive chemotherapy (PC) with albendazole (ALB) mebendazole (MEB) least 75 % all endemic areas by 2020. Here, we predict feasibility achieving infection, based on...

10.1186/s13071-015-1151-4 article EN cc-by Parasites & Vectors 2015-10-15
Coming Soon ...